Drug Discovery Today: Technologies最新文献_第3页

Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters 数据独立获取(DIA):一种新兴的蛋白质组学技术，用于分析药物代谢酶和转运蛋白

Drug Discovery Today: Technologies Pub Date : 2021-12-01 DOI: 10.1016/j.ddtec.2021.06.006

Jiapeng Li, Logan S. Smith, Hao-Jie Zhu

{"title":"Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters","authors":"Jiapeng Li, Logan S. Smith, Hao-Jie Zhu","doi":"10.1016/j.ddtec.2021.06.006","DOIUrl":"10.1016/j.ddtec.2021.06.006","url":null,"abstract":"<div>Data-independent acquisition (DIA) proteomics is a recently-developed global mass spectrometry (MS)-based proteomics strategy. In a DIA method, precursor ions are isolated into pre-defined isolation windows and fragmented; all fragmented ions in each window are then analyzed by a high-resolution mass spectrometer. DIA proteomics analysis is characterized by a broad protein coverage, high reproducibility, and accuracy, and its combination with advances in other techniques such as sample preparation and computational data analysis could lead to further improvements in assay performances. DIA technology has been increasingly utilized in various proteomics studies, including quantifying drug-metabolizing enzymes and transporters. Quantitative proteomics study of drug-metabolizing enzymes and transporters could lead to a better understanding of pharmacokinetics and pharmacodynamics and facilitate drug development. This review summarizes the application of DIA technology in proteomic analysis of drug-metabolizing enzymes and transporters.</div>","PeriodicalId":36012,"journal":{"name":"Drug Discovery Today: Technologies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddtec.2021.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39587150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 14

Development of biotherapeutics and biosimilars 生物治疗药物和生物仿制药的发展

Drug Discovery Today: Technologies Pub Date : 2021-12-01 DOI: 10.1016/j.ddtec.2021.10.006

Zoltán Urbányi

引用次数: 0

From computer-aided drug discovery to computer-driven drug discovery 从计算机辅助药物发现到计算机驱动药物发现

Drug Discovery Today: Technologies Pub Date : 2021-12-01 DOI: 10.1016/j.ddtec.2021.08.001

Leah Frye, Sathesh Bhat, Karen Akinsanya, Robert Abel

{"title":"From computer-aided drug discovery to computer-driven drug discovery","authors":"Leah Frye, Sathesh Bhat, Karen Akinsanya, Robert Abel","doi":"10.1016/j.ddtec.2021.08.001","DOIUrl":"10.1016/j.ddtec.2021.08.001","url":null,"abstract":"<div>Computational chemistry and structure-based design have traditionally been viewed as a subset of tools that could aid acceleration of the drug discovery process, but were not commonly regarded as a driving force in small molecule drug discovery. In the last decade however, there have been dramatic advances in the field, including (1) development of physics-based computational approaches to accurately predict a broad variety of endpoints from potency to solubility, (2) improvements in artificial intelligence and deep learning methods and (3) dramatic increases in computational power with the advent of GPUs and cloud computing, resulting in the ability to explore and accurately profile vast amounts of drug-like chemical space in silico. There have also been simultaneous advancements in structural biology such as cryogenic electron microscopy (cryo-EM) and computational protein-structure prediction, allowing for access to many more high-resolution 3D structures of novel drug-receptor complexes. The convergence of these breakthroughs has positioned structurally-enabled computational methods to be a driving force behind the discovery of novel small molecule therapeutics. This review will give a broad overview of the synergies in recent advances in the fields of computational chemistry, machine learning and structural biology, in particular in the areas of hit identification, hit-to-lead, and lead optimization.</div>","PeriodicalId":36012,"journal":{"name":"Drug Discovery Today: Technologies","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddtec.2021.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39725780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 22

Application of proteomic data in the translation of in vitro observations to associated clinical outcomes 蛋白质组学数据在将体外观察转化为相关临床结果中的应用

Drug Discovery Today: Technologies Pub Date : 2021-12-01 DOI: 10.1016/j.ddtec.2021.06.002

Sibylle Neuhoff , Matthew D. Harwood , Amin Rostami-Hodjegan , Brahim Achour

引用次数: 3

Synthetic carbohydrate-based HIV-1 vaccines 合成碳水化合物为基础的HIV-1疫苗

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2020.09.004

Iñaki Bastida , Alberto Fernández-Tejada

引用次数: 5

Microcrystal electron diffraction in macromolecular and pharmaceutical structure determination 微晶电子衍射在大分子和药物结构测定中的应用

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2020.12.002

Max T.B. Clabbers , Hongyi Xu

引用次数: 9

Antibody-drug conjugates as targeted therapies: Are we there yet? A critical review of the current clinical landscape 抗体-药物结合作为靶向治疗:我们还在那里吗?对当前临床前景的批判性回顾

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2020.07.002

Edit Tarcsa , Magali R. Guffroy , Hadi Falahatpisheh , Colin Phipps , John C. Kalvass

引用次数: 15

Bacterial polysaccharides: conformation, dynamics and molecular recognition by antibodies 细菌多糖:构象、动力学和抗体的分子识别

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2020.08.002

Marcos Gómez-Redondo , Ana Ardá , Ana Gimeno , Jesús Jiménez-Barbero

引用次数: 5

Erratum regarding missing Declaration of Competing Interest statements in previously published articles 关于先前发表的文章中缺少竞争利益声明的勘误表

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2021.01.002

引用次数: 0

Carbohydrate-based adjuvants 基质佐剂

Drug Discovery Today: Technologies Pub Date : 2020-12-01 DOI: 10.1016/j.ddtec.2020.09.005

Pilar Garcia-Vello , Immacolata Speciale , Fabrizio Chiodo , Antonio Molinaro , Cristina De Castro

引用次数: 19